1GIAMARELLOS-BOURBOULIS E J. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators[J]. Int J Antimicrob Agents, 2008, 31 (1): 12-20.
2SHINKAI M, FOSTER G H, RUBIN B K. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells [J]. Am J Physiol Lung Cell Mol Physiol, 2006, 290 ( 1 ) : L75-L85.
3SHINKAI M, LOPEZ-BOADO Y S, RUBIN B K. Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin[J]. J Antimicrob Chemother, 2007, 59 (6): 1096-1101.
8AGHAI Z H, KODE A, SASLOW J G, et al. Azithro-mycin suppresses activation of nuclear factorkappa B and synthesis of pro-inflammatory cytokines in trachea] aspirate cells from premature infants [ J ]. Pediatr Res, 2007, 62 (4) : 483-488.
9OUX M, FENG Y L, WEN F Q, et al. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB [ J ]. Respirology, 2008, 13 (1) : 63-72.
10HODGE S, HODGE G, BROZYNA S, et al. Azithro- mycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages [ J ]. Eur Respir J, 2006, 28 (3): 486-495.
5Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma [J]. Chest, 1991,99(3):670-3.
6O' Byrne PM, Walters EH, Gold BD, et al. Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure [J]. Am Rev Respir Dis, 1984,130(2):214-9.
7Anderson R Theron AJ, Feldman C. Anti-inflammatory interactions of macrolides with human neutrophils [J]. Inflammation, 1996,20(6):693-705.
8Sontag SJ, Connell SO, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy [J]. Gastroenterology, 1990,99(3):613-20.
